Rectal cancer stage III – Basic Information

Go back

Stage III rectal cancer represents a significant turning point in the journey of someone diagnosed with cancer in the lower part of their digestive system, marking a stage where the disease has moved beyond the rectum’s inner layers to reach nearby tissues but remains within a treatable zone.

What Stage III Rectal Cancer Means

Stage III rectal cancer is a specific classification that describes how far cancer has traveled from its starting point in the rectum. At this stage, the cancer has grown through various layers of the rectal wall and has spread into nearby lymph nodes, which are small bean-shaped structures that filter harmful substances from the body. However, the cancer has not yet reached distant organs like the liver or lungs[2][6].

The rectum makes up the last several inches of the large intestine, typically measuring six to eight inches long. Together with the anal canal, it forms the final part of the digestive system before waste leaves the body. When cells in this area begin to grow abnormally and uncontrollably, they can form cancerous tumors that invade surrounding tissues[3].

Stage III rectal cancer is further divided into three subcategories: IIIA, IIIB, and IIIC. These subdivisions depend on how deeply the cancer has grown into the rectal wall and how many lymph nodes contain cancer cells. In stage IIIA, the cancer may be in the inner or muscle layer of the bowel wall and has spread to one to three nearby lymph nodes, or it’s in the inner layer and has reached four to six lymph nodes[6].

Stage IIIB indicates that the cancer has grown into the outer lining of the bowel wall or the tissue covering organs in the abdomen and has spread to one to three nearby lymph nodes, or it’s in the muscle or outer lining with four to six affected lymph nodes, or it remains in inner or muscle layers but has reached seven or more lymph nodes[6].

Stage IIIC represents the most advanced form of stage III disease. At this point, the cancer has grown through the outer lining into the tissue covering abdominal organs with four to six affected lymph nodes, or it’s in the outer lining with seven or more affected lymph nodes, or it has grown through the bowel wall into nearby organs with at least one affected lymph node[6].

How Common Is This Diagnosis

Rectal cancer represents the third most common cancer affecting the digestive system, following colon cancer and pancreatic cancer. Medical experts estimate that approximately 46,200 people receive a rectal cancer diagnosis each year in the United States alone[7].

Understanding who gets rectal cancer requires looking at several patterns. The average age at diagnosis is 63 years, meaning that most people who develop this condition are older adults. However, this doesn’t mean younger individuals are immune; the disease can occur at any age[7].

When examining gender differences, men face a slightly higher likelihood of developing rectal cancer compared to women. Additionally, statistical data shows that people who are Black experience higher rates of rectal cancer diagnosis and mortality, though the reasons behind these disparities involve complex factors including access to healthcare, screening rates, and biological differences[7].

The progression from early-stage to stage III disease often takes time. Rectal cancer typically begins as abnormal cell clusters called polyps or adenomas on the inner lining of the rectum. These precancerous growths can take ten to fifteen years to develop into invasive cancer. This long timeline explains why regular screening through procedures like colonoscopy can prevent many cases by detecting and removing polyps before they become cancerous[7].

What Causes Rectal Cancer to Develop

The exact cause of rectal cancer remains unknown, but scientists understand it develops through changes in how cells in the rectal lining function, particularly affecting how they grow and divide into new cells. These changes typically result from damage to the cell’s DNA, the genetic instruction manual that tells cells how to behave[3].

Cancer doesn’t usually happen overnight or from a single event. Instead, it develops over many years as cells accumulate multiple genetic changes that allow them to ignore normal growth controls, avoid death signals, invade nearby tissues, and eventually spread to other body parts. The transformation from normal cells to cancer involves a series of steps, which explains why the disease often takes years or decades to develop[3].

While we cannot pinpoint a single cause for any individual case of rectal cancer, research has identified numerous risk factors that increase someone’s chances of developing the disease. Having a biological family member such as a parent, sibling, or child with a history of colon or rectal cancer nearly doubles one’s risk, suggesting that inherited genetic factors play a role[3].

Certain inherited genetic conditions significantly increase rectal cancer risk. Lynch syndrome, also called hereditary nonpolyposis colorectal cancer, and familial adenomatous polyposis (FAP) are two conditions caused by specific gene mutations passed from parents to children. People with these syndromes face much higher lifetime risks of developing colorectal cancers and often at younger ages[3].

A personal history of colon, rectal, or ovarian cancer increases the risk of developing a new rectal cancer. Similarly, having a history of high-risk adenomas—polyps that are one centimeter or larger or have abnormal-looking cells under a microscope—raises risk considerably[3].

Chronic inflammatory conditions of the intestines also contribute to increased risk. People who have lived with ulcerative colitis or Crohn’s disease for eight years or more face elevated chances of developing colorectal cancer. These conditions cause ongoing inflammation in the intestinal lining, which over time can lead to cellular changes that promote cancer development[3].

Risk Factors That Increase Your Chances

Beyond genetic and medical history factors, several lifestyle elements influence rectal cancer risk. Diet plays a meaningful role; people who regularly consume large amounts of red meat and processed meats face higher risk compared to those who eat these foods less frequently. The reasons for this connection aren’t completely clear but may involve compounds formed during meat processing or high-temperature cooking[3].

Alcohol consumption represents another modifiable risk factor. Having three or more alcoholic drinks per day increases the likelihood of developing colorectal cancer. Alcohol may contribute to cancer development through several mechanisms, including damaging DNA, affecting how the body absorbs certain nutrients, and increasing levels of certain hormones[3].

Smoking cigarettes affects more than just lung health. Recent research demonstrates that people who smoke tobacco are more likely to die from rectal cancer than those who don’t smoke. Tobacco contains numerous cancer-causing chemicals that can reach and affect tissues throughout the body, including the digestive system[7].

Obesity emerges as another significant risk factor. People carrying excess body weight face higher rates of rectal cancer compared to those maintaining healthy weights. Extra body fat doesn’t just sit passively; it actively produces hormones and inflammatory substances that can promote cancer development[3].

Age itself represents one of the strongest risk factors for most cancers, including rectal cancer. The chance of getting cancer increases steadily as people grow older, partly because cells accumulate more genetic damage over time and partly because the body’s ability to repair DNA damage and eliminate abnormal cells declines with age[3].

⚠️ Important
Having one or more risk factors does not mean you will definitely develop rectal cancer. Many people with multiple risk factors never develop the disease, while others with no known risk factors do get cancer. Risk factors simply indicate increased probability, not certainty. If you think you might face elevated risk, discuss screening and prevention strategies with your doctor.

Recognizing the Symptoms

Many people with rectal cancer, especially in earlier stages, experience no symptoms at all. Cancer can grow for years without causing noticeable changes, which explains why regular screening matters so much for early detection. However, when symptoms do appear, they warrant prompt medical attention[7].

Rectal bleeding represents one of the most common warning signs. People might notice blood in their stool, on toilet paper, or in the toilet bowl. The blood may appear bright red or darker, depending on where in the digestive tract the bleeding originates. While hemorrhoids and other benign conditions commonly cause rectal bleeding, any instance of blood in or around stool deserves medical evaluation[7].

Changes in bowel habits can signal rectal cancer. Someone might develop diarrhea that persists beyond a few days, or they might experience constipation that doesn’t resolve with typical remedies. The pattern and timing of bowel movements may shift suddenly, or the shape of stool might change, appearing stringy or as thin as a pencil. These changes occur because a growing tumor can narrow the rectal passage or interfere with normal muscle function[7].

Some people notice they cannot control their bowel movements as well as before, experiencing unexpected urgency or leakage. Others might feel that their bowel doesn’t empty completely after a bathroom visit. Bowel obstruction can occur if a tumor grows large enough to block the passage of stool, causing severe constipation, pain, and bloating[18].

Abdominal discomfort manifests in various ways. People might experience cramping, bloating, or persistent pain in the belly area. The abdomen might feel uncomfortably full or tight even after eating small amounts[7].

General symptoms affecting the whole body can also occur. Unexplained weight loss—losing pounds without trying through diet or exercise changes—may happen as cancer affects metabolism and appetite. Many people feel persistently tired or weak, a condition called fatigue that doesn’t improve with rest. Loss of appetite can lead to eating less than usual, contributing to weight loss and nutritional deficiencies. Some individuals develop anemia, a condition where the body doesn’t have enough healthy red blood cells to carry adequate oxygen to tissues, causing tiredness, weakness, and sometimes shortness of breath[7][18].

How Prevention and Early Detection Work

While not all rectal cancers can be prevented, many cases are avoidable through lifestyle modifications and regular screening. Prevention starts with addressing modifiable risk factors. Maintaining a healthy body weight through balanced nutrition and regular physical activity reduces risk. Limiting consumption of red and processed meats while increasing intake of fruits, vegetables, and whole grains may offer protective benefits[3].

Reducing alcohol consumption to no more than two drinks per day for men and one for women, or avoiding alcohol entirely, lowers risk. Quitting smoking eliminates the cancer-promoting effects of tobacco and improves overall health in numerous ways[3].

Regular screening represents the most powerful tool for preventing rectal cancer deaths. Screening tests can find precancerous polyps before they turn into cancer, allowing doctors to remove them during the same procedure. Screening also detects cancers at early stages when treatment is most effective and cure rates are highest[7].

The most comprehensive screening test is colonoscopy, a procedure where a doctor examines the entire colon and rectum using a flexible tube with a camera. During colonoscopy, any polyps discovered can be removed immediately, directly preventing future cancers. Current guidelines generally recommend that people at average risk begin regular colonoscopy screening at age 45[7].

People with higher risk due to family history, inherited genetic conditions, or inflammatory bowel disease may need to start screening earlier and undergo testing more frequently. Discussing personal risk factors with a healthcare provider helps determine the most appropriate screening schedule[3].

Other screening methods exist, including stool-based tests that look for blood or abnormal DNA in stool samples, and imaging tests like CT colonography. While these alternatives offer convenience, they may not detect all polyps or cancers, and positive results require follow-up colonoscopy[7].

Understanding What Happens in the Body

To understand stage III rectal cancer’s pathophysiology—the changes in normal body functions caused by disease—it helps to know how cancer progresses through the layers of the rectal wall. The rectum’s wall consists of several distinct layers, each with different structures and functions.

The innermost layer, called the mucosa, forms the lining that comes in contact with stool passing through. Just beneath this sits the submucosa, a layer containing blood vessels, nerves, and lymphatic vessels. Next comes the muscularis propria, the thick muscle layer that contracts to move waste along. Outside this lies the serosa or outer covering, though the rectum has less serosa than other parts of the colon[6].

In stage III rectal cancer, malignant cells have grown beyond the mucosa where they originated and invaded through deeper layers. The cancer has also reached nearby lymph nodes, which is significant because lymph nodes are connected by a network of lymphatic vessels throughout the body. Once cancer cells enter lymph nodes, they have accessed a highway system that could potentially carry them to distant locations[2].

The presence of cancer in lymph nodes indicates more aggressive disease than when cancer remains confined to the rectal wall alone. However, stage III disease is distinguished from stage IV by the absence of distant metastases—cancer spread to distant organs like the liver, lungs, or other body parts. This distinction matters tremendously for treatment planning and prognosis[2].

As tumors grow, they can interfere with normal rectal function in several ways. A growing mass narrows the rectal passage, potentially leading to changes in stool caliber, difficulty passing stool, and eventually obstruction. Tumors damage blood vessels in the rectal wall, causing bleeding that appears in stool or leads to anemia. The cancer can infiltrate nerves, causing pain or affecting the ability to control bowel movements. Inflammation around the tumor produces symptoms like cramping, urgency, and changes in bowel habits[7].

Cancer cells behave differently than normal cells in fundamental ways. They ignore signals that tell normal cells to stop dividing, allowing them to multiply continuously. They resist signals that would normally cause damaged or unnecessary cells to die. They can stimulate the growth of new blood vessels to supply themselves with nutrients and oxygen. They develop the ability to invade surrounding tissues and, in stage III disease, to survive in lymph nodes where normal rectal cells could not[3].

Understanding these biological processes helps explain both the symptoms people experience and the rationale behind different treatment approaches. Treatments aim to eliminate cancer cells while minimizing harm to normal tissues, addressing both the primary tumor and the microscopic disease that may exist in lymph nodes and surrounding areas.

Ongoing Clinical Trials on Rectal cancer stage III

  • Study comparing treatment with or without tislelizumab for patients with locally advanced rectal cancer to see if surgery can be avoided

    Recruiting

    1 1
    Investigated drugs:
    Germany
  • Study Comparing Short-Course Radiotherapy and Drug Combination for Older Patients with Locally Advanced Rectal Cancer

    Recruiting

    1 1 1 1
    Belgium
  • Study on Oxaliplatin and Capecitabine for Patients with Locally Advanced Rectal Cancer

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Italy
  • Study of Regorafenib and Nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium
  • Study on Short-Course Radiotherapy and Chemotherapy with Fluorouracil, Irinotecan, and Oxaliplatin for Patients with Locally Advanced Rectal Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Italy

References

https://www.texasoncology.com/types-of-cancer/rectal-cancer/stage-iii-rectal-cancer

https://colorectalcancer.org/basics/stages-colorectal-cancer/stage-iii

https://www.cancer.gov/types/colorectal/patient/rectal-treatment-pdq

https://www.mskcc.org/cancer-care/types/rectal/diagnosis/stages

https://www.mayoclinic.org/diseases-conditions/rectal-cancer/stages/gnc-20589091

https://www.cancerresearchuk.org/about-cancer/bowel-cancer/stages-types-and-grades/stage-three

https://my.clevelandclinic.org/health/diseases/21733-rectal-cancer

FAQ

What’s the difference between stage III rectal cancer and stage III colon cancer?

Both involve cancer spread to nearby lymph nodes without distant metastases, but rectal cancers are treated differently because the rectum’s location in the pelvis makes surgery more complex and the lack of serosa increases local recurrence risk. Rectal cancer typically receives radiation therapy as part of treatment, while colon cancer usually does not.

How is stage III rectal cancer typically treated?

In the United States, standard treatment typically involves chemotherapy and radiation given before surgery to shrink the tumor, followed by surgical removal of the cancer several weeks later, then additional chemotherapy for approximately four months. The specific treatment plan depends on the tumor’s exact location and characteristics.

Can you live a normal life after stage III rectal cancer treatment?

Many people return to normal or near-normal activities after completing treatment for stage III rectal cancer. Some may have permanent changes such as a colostomy, altered bowel function, or treatment-related side effects, but with proper support and management, most survivors adapt and maintain good quality of life.

What does it mean if cancer has spread to lymph nodes?

When cancer reaches nearby lymph nodes, it indicates more advanced local disease and higher risk of recurrence compared to cancer confined to the rectal wall. However, it doesn’t mean the cancer has spread throughout the body. The number and location of affected lymph nodes help doctors plan treatment and estimate prognosis.

Will I need a permanent colostomy if I have stage III rectal cancer?

Not everyone with stage III rectal cancer needs a permanent colostomy. Whether one is needed depends on the tumor’s location in the rectum, how close it is to the anal sphincter muscles, and how it responds to pre-surgery treatment. Many patients receive only temporary colostomies that are reversed after healing, and some require no colostomy at all.

🎯 Key Takeaways

  • Stage III rectal cancer means the disease has spread to nearby lymph nodes but not to distant organs, making it more advanced than stages I and II but still potentially curable with aggressive treatment.
  • Most rectal cancers develop slowly from precancerous polyps over 10 to 15 years, making regular colonoscopy screening a powerful prevention tool that can stop cancer before it starts.
  • The average age of diagnosis is 63, but younger people can develop rectal cancer, especially those with family history or inherited genetic conditions like Lynch syndrome.
  • Rectal bleeding, changes in bowel habits, narrow stools, and unexplained weight loss are common symptoms, though many people have no symptoms until the disease is advanced.
  • Lifestyle factors including diet high in red and processed meats, excessive alcohol consumption, smoking, and obesity all increase rectal cancer risk and are modifiable.
  • Stage III is divided into subcategories (IIIA, IIIB, IIIC) based on how deeply cancer has invaded the rectal wall and how many lymph nodes contain cancer cells.
  • Treatment in the United States typically involves radiation and chemotherapy before surgery, followed by additional chemotherapy, though approaches vary by location and individual case.
  • Having risk factors doesn’t guarantee you’ll develop cancer, and having no known risk factors doesn’t mean you’re immune—regular screening remains important for everyone.